Harmjan R. Vos

3.8k citations

58 papers · 1.8k indexed · h-index 24

Co-authors: Boudewijn Burgering Tobias B. Dansen Albert J. R. Heck Joost W. Gouw Martijn W. H. Pinkse Xiaogang Zhang Willem Stoorvogel Hendrik A. Raué
Topics: RNA Research and Splicing (10 papers)RNA modifications and cancer (9 papers)RNA and protein synthesis mechanisms (7 papers)
Cited by: Aging Molecular Biology Cancer Research
Journals: Nucleic Acids Research Journal of Biological Chemistry Nature Communications
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Harmjan R. Vos

57 papers receiving 1.8k citations

Peers

Countries citing papers authored by Harmjan R. Vos

Since Specialization

Citations

This map shows the geographic impact of Harmjan R. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harmjan R. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harmjan R. Vos more than expected).

Fields of papers citing papers by Harmjan R. Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harmjan R. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harmjan R. Vos. The network helps show where Harmjan R. Vos may publish in the future.

Co-authorship network of co-authors of Harmjan R. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Harmjan R. Vos. A scholar is included among the top collaborators of Harmjan R. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harmjan R. Vos. Harmjan R. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Calcineurin-NFAT-DSCR1.4 signaling as druggable axis in Gαq-R183Q–driven capillary malformations 2026 ·Angiogenesis ·(unknown),(unknown),Nathalie R. Reinhard,(unknown),Robert M. van Es,(unknown),(unknown),(unknown),(unknown),(unknown),Nicanor I. Moldovan,Harmjan R. Vos,Stephan Huveneers	0
2	E-cadherin mechanotransduction activates EGFR-ERK signaling in epithelial monolayers by inducing ADAM-mediated ligand shedding 2025 ·Science Signaling ·(unknown),(unknown),Marjolein J. Vliem,(unknown),(unknown),(unknown),Joo Yong Sim,(unknown),Kenta Terai,Matthew A. Hopcroft,Harmjan R. Vos,Beth L. Pruitt,Michiyuki Matsuda,Willem‐Jan Pannekoek,Martijn Gloerich	1
3	Aberrant neurodevelopment in human iPS cell‐derived models of Alexander disease 2024 ·Glia ·(unknown),(unknown),Yolanda de Pablo,(unknown),Isaac Canals,(unknown),Harmjan R. Vos,Dolores Pérez‐Sala,Mikael Kubista,Pavel Abaffy,Henrik Ahlenius,Lukáš Valihrach,Elly M. Hol,Milos Pekny	2
4	Isoleucine-to-valine substitutions support cellular physiology during isoleucine deprivation 2024 ·Nucleic Acids Research ·(unknown),Imre F. Schene,(unknown),(unknown),Marisa I. Mendes,Desirée E.C. Smith,Gajja S. Salomons,(unknown),Judith Jans,(unknown),Tim A. Hoek,(unknown),Holger Rehmann,Edward E. S. Nieuwenhuis,Harmjan R. Vos,Sabine A. Fuchs	1
5	Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids 2024 ·Frontiers in Immunology ·(unknown),(unknown),Lowiek M. Hubers,Dagmar Tolenaars,Harmjan R. Vos,Stan F.J. van de Graaf,Ulrich Beuers	8
6	Metabolic rewiring in keratinocytes by miR‐31‐5p identifies therapeutic intervention for psoriasis 2023 ·EMBO Molecular Medicine ·Maojie Wang,(unknown),(unknown),Harmjan R. Vos,(unknown),Edwin C.A. Stigter,(unknown),Marc Pagès-Gallego,(unknown),Li Li,Hao Deng,Han Lin,Runyue Huang,Chuanjian Lu,Boudewijn Burgering	13
7	Early adipogenesis is repressed through the newly identified FHL2-NFAT5 signaling complex 2023 ·Cellular Signalling ·(unknown),Miguel Hernández-Quiles,(unknown),Miesje M. van der Stoel,(unknown),(unknown),J. van den Burg,Aldo Jongejan,(unknown),(unknown),Harmjan R. Vos,Eric Kalkhoven,Carlie J.M. de Vries	4
8	FER regulates endosomal recycling and is a predictor for adjuvant taxane benefit in breast cancer 2022 ·Cell Reports ·(unknown),Nalan Liv,(unknown),Mark Opdam,(unknown),(unknown),(unknown),Rutger C.C. Hengeveld,(unknown),Erik van Werkhoven,Harmjan R. Vos,Holger Rehmann,Boudewijn Burgering,Hendrika M. Oosterkamp,Susanne M.A. Lens,Judith Klumperman,Sabine C. Linn,Patrick W.B. Derksen	7
9	Diverse BRAF Gene Fusions Confer Resistance to EGFR-Targeted Therapy via Differential Modulation of BRAF Activity 2020 ·Molecular Cancer Research ·(unknown),(unknown),Markus J. van Roosmalen,Nizar Hami,Ingrid Verlaan-Klink,Harmjan R. Vos,Robert M. van Es,Marco J. Koudijs,Emile E. Voest,Hugo J.G. Snippert,Wigard P. Kloosterman	11
10	Proteomic Profiling of Two Distinct Populations of Extracellular Vesicles Isolated from Human Seminal Plasma 2020 ·International Journal of Molecular Sciences ·Xiaogang Zhang,Harmjan R. Vos,Weiyang Tao,Willem Stoorvogel	31
11	Nemo-like Kinase Drives Foxp3 Stability and Is Critical for Maintenance of Immune Tolerance by Regulatory T Cells 2019 ·Cell Reports ·Veerle Fleskens,Carlos M. Minutti,Xingmei Wu,Ping Wei,Cornelieke Pals,James McCrae,Saskia Hemmers,Vincent Groenewold,Harmjan R. Vos,Alexander Y. Rudensky,Fan Pan,Huabin Li,Dietmar M. Zaiss,Paul J. Coffer	39
12	Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease 2017 ·Gut ·Lowiek M. Hubers,Harmjan R. Vos,Alex R. Schuurman,(unknown),Ronald P.J. Oude Elferink,Boudewijn Burgering,Stan F.J. van de Graaf,Ulrich Beuers	132
13	Germline mutations affecting the histone H4 core cause a developmental syndrome by altering DNA damage response and cell cycle control 2017 ·Nature Genetics ·(unknown),Federico Tessadori,Jacques C. Giltay,Jane A. Hurst,Maarten P.G. Massink,Karen Duran,Harmjan R. Vos,Robert M. van Es,Richard H. Scott,Koen L.I. van Gassen,Jeroen Bakkers,Gijs van Haaften	34
14	ZMYND8 Co-localizes with NuRD on Target Genes and Regulates Poly(ADP-Ribose)-Dependent Recruitment of GATAD2A/NuRD to Sites of DNA Damage 2016 ·Cell Reports ·Cornelia G. Spruijt,Martijn S. Luijsterburg,Roberta Menafra,Rik G.H. Lindeboom,Pascal W.T.C. Jansen,Raghu Ram Edupuganti,Marijke Baltissen,Wouter W. Wiegant,(unknown),Filomena Matarese,Anneloes Mensinga,Ina Poser,Harmjan R. Vos,Hendrik G. Stunnenberg,Haico van Attikum,Michiel Vermeulen	85
15	Proteome-wide Changes in Protein Turnover Rates in C. elegans Models of Longevity and Age-Related Disease 2016 ·Cell Reports ·Marieke Visscher,Sasha De Henau,Mattheus H. E. Wildschut,Robert M. van Es,Ineke Dhondt,Helen Michels,Patrick Kemmeren,Ellen A. A. Nollen,Bart P. Braeckman,Boudewijn Burgering,Harmjan R. Vos,Tobias B. Dansen	49
16	Evolutionary Acquisition of Cysteines Determines FOXO Paralog-Specific Redox Signaling 2014 ·Antioxidants and Redox Signaling ·Marrit Putker,Harmjan R. Vos,(unknown),Hesther de Ruiter,(unknown),‎Berend Snel,Boudewijn Burgering,Michiel Vermeulen,Tobias B. Dansen	55
17	Wip1 phosphatase is associated with chromatin and dephosphorylates γH2AX to promote checkpoint inhibition 2010 ·Oncogene ·Libor Macůrek,Arne Lindqvist,(unknown),Jacob L. Kool,Harmjan R. Vos,René H. Medema	117
18	Rrp5p, a trans-acting factor in yeast ribosome biogenesis, is an RNA-binding protein with a pronounced preference for U-rich sequences 2006 ·RNA ·Paulo de Boer,Harmjan R. Vos,Alex W. Faber,J. Chris Vos,Hendrik A. Raué	23
19	The RNA catabolic enzymes Rex4p, Rnt1p, and Dbr1p show genetic interaction with trans-acting factors involved in processing of ITS1 in Saccharomyces cerevisiae pre-rRNA 2004 ·RNA ·Alex W. Faber,J. Chris Vos,Harmjan R. Vos,(unknown),Sherif Abou Elela,Hendrik A. Raué	14
20	Yeast Rrp9p is an evolutionarily conserved U3 snoRNP protein essential for early pre-rRNA processing cleavages and requires box C for its association 2000 ·RNA ·Jaap Venema,Harmjan R. Vos,Alex W. Faber,Walther J. van Venrooij,Hendrik A. Raué	57

About Harmjan R. Vos

Harmjan R. Vos is a scholar working on Aging, Cell Biology and Molecular Biology, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA Research and Splicing (10 papers), RNA modifications and cancer (9 papers) and RNA and protein synthesis mechanisms (7 papers). The work is most often cited by research in Aging (112 citations), Molecular Biology (1.3k citations) and Cancer Research (188 citations). Harmjan R. Vos has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Boudewijn Burgering, Tobias B. Dansen, Albert J. R. Heck, Joost W. Gouw, Martijn W. H. Pinkse, Xiaogang Zhang, Willem Stoorvogel, Hendrik A. Raué, Alex W. Faber and Shabaz Mohammed. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact